• New Portable Anti-Counterfeiting Technology Promises 'Paradigm Shift'

    • 02 August 2012
    The US Pharmacopoeia (USP) has developed a new technology that holds the promise of detecting substandard and counterfeit medicines with greater accuracy, sensitivity and reliability than other field-based portable tools. In a statement , USP said the development of the technology, called "PharmaCheck," was done in response to a challenge from the Bill & Melinda Gates Foundation and the needs of patients in the developing world. "Substandard and counterfeit medicin...
  • After Counterfeit Avastin Infiltrates Supply Chain, FDA Goes After Doctors

    The US Food and Drug Administration (FDA) is going after doctors in an attempt to protect the pharmaceutical supply chain from more instances of counterfeit medicines, reports Medscape News . There have been two instances of fake Avastin being found in the US in 2012-one in early April and another in mid-February . Both cases involved doctors deviating from approved suppliers to purchase Avastin from unauthorized wholesalers. While FDA Commissioner Margaret Hamburg ...
  • Indian Task Force Recommends Adoption of Authentication System for Pharmaceuticals

    Taking a page out of the anti-counterfeiters' playbook, a high-level Indian task force has recommended the adoption of verification technology and mobile text messaging authentication for medicines produced and sold in India, reports BioSpectrum Asia . The technology is already in use in some African countries such as Kenya and Ghana , but the adoption scale recommended by the Union Health Ministry's task force on pharmaceutical manufacturing would dwarf those in sca...
  • Woodcock Calls for Prescription Drug Tracking System

    The US Food and Drug Administration (FDA) is calling for a prescription drug tracking system to ensure the pharmaceutical supply chain's integrity, reports The Financial Times . Janet Woodcock, director of FDA's Center for Drug Evaluation and Research, testified before the House Energy and Commerce Committee on 8 March and called for Congress to grant FDA additional authority to secure the supply chain. "Currently there is no complete record of all parties who have b...